SCHEMBL21393358

SCHEMBL21393358

C=Cn1c(C=O)c(C)ccc1=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21393695 0.64 TRIM24 (0.38)
SCHEMBL8604090 0.59 CA12 (0.52) SMN1; SMN2
SCHEMBL29611953 0.59 CA12 (0.52) SMN1; SMN2
SCHEMBL11529888 0.57 NPC1 (0.38) SMN1; SMN2
SCHEMBL27589630 0.57
SCHEMBL14993028 0.57
SCHEMBL21393694 0.57 CA12 (0.32) SMN1; SMN2
SCHEMBL21393349 0.57 IDH1 (0.37)
SCHEMBL31666972 0.56 SMN1; SMN2 (0.36) SMN1; SMN2
SCHEMBL3420520 0.56 ALDH1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182925-A1 OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS GENENTECH, INC. (US) 2019-09-26 WO disclosed